We developed simple, reliable, and highly sensitive assay modifications of commercially available radioimmunoassay kits to measure estradiol in saliva and blood spot specimens. The saliva assay has average intra-and interassay coefficients of variation (CV) of 6.45 and 9.01%, with average analytical and serial dilution recoveries 100.65 and 89.25%. The blood spot assay has average intra-and interassay CVs of 7.57 and 8.22%, with analytical and serial dilution recoveries of 80.50 and 108.50%. The analytical sensitivity ranges of the saliva (0.25-7.50 pg/ml) and blood spot (2.00 -375 pg/ml) assays are sufficient to determine levels in the majority of pre-and postpubertal males and females. Blood spot assay results are correlated with serum estradiol levels for adult males, r (17) ‫؍‬ 0.73, and females, r (18) ‫؍‬ 0.96. In contrast, the serum-saliva correlation is only modest for adult females, r (14) ‫؍‬ 0.60, and not significant for adult males. Substitution of blood spot assay results for serum values underestimates the known serum estradiol-behavior correlation by only 3.45%, whereas substitution of saliva assay results for serum values underestimates the association by 37.55%. The findings have important implications for the use and potential misuse of noninvasive measures of estradiol in studies of health and human development. © 2000 Academic Press
Research on estradiol has focused predominantly on reproductive issues, such as conception, ovulation, infertility, and menopause. Yet, estradiol affects a diversity of biological processes involved with pubertal and reproductive capacity, establishment and maintenance of pregnancy, infant care (Booth, Carver, and Granger, 2000; Uvnas-Moberg, Widstrom, Nissen, and Bjorvell, 1990) , coronary artery disease, immunocompetence, and cancer susceptibility (McEwen, 1999) . Estradiol also is believed to affect individual differences in cognitive and socioemotional processes (McEwen, 1999; Rodriguez and Grossberg, 1998) , as well as psychopathology (Seeman, 1997; Zweifel and O'Brien, 1997) . For these reasons, it is not surprising that there is an emerging consensus among developmental and health-oriented scientists that monitoring estradiol levels in the next generation of biobehavioral studies is worthwhile.
Recent studies suggest that estradiol can be accurately measured in saliva (Belkien, Bordt, Moller, Hano, and Nieschlag, 1985; Choe, Khan-Dawood, and Dawood, 1982; Lipson and Ellison, 1996; Lu, Bentley, Gann, Hodges, and Chatterton, 1999; O'Rourke and Ellison, 1993; Worthman, Stallings, and Hofman, 1990) or blood spots (Worthman and Stallings, 1997) . With few exceptions, scant information is available to guide researchers on the use of these alternatives to serum measures in behaviorally oriented studies. This paper presents a rigorous evaluation of the internal and external validity of salivary and blood spot estradiol radioimmunoassays (RIAs) and provides specific recommendations for their application.
Monitoring estradiol in saliva has several advantages. Collection techniques are less invasive than venipuncture, affording researchers the ability to conduct repeated sampling over the course of minutes, hours, days, or longer. Research assistants or subjects can, with minimal training, easily collect saliva samples. Also, saliva is not considered a class II biohazard (U.S. Centers for Disease Control) when it is not visibly contaminated with blood, affording researchers' safety and handling benefits. Salivary levels of estradiol are believed to accurately represent the biologically active fraction in the general circulation (RiadFahmy, Read, Walker, Walker, and Griffiths, 1987; Vining, McGinley, and Symons, 1983) .
Monitoring estradiol in saliva is not without disadvantages. Salivary levels of estradiol are estimated to be between 0.20 and 7.90% of that in the circulation (Lu et al., 1999) . Consequently, levels of estradiol in saliva may often be too low to be reliably measured by immunoassay. For instance, expected values are Ͻ5 pg/ml for prepubertal children and adult males and females (at the low point in the menstrual cycle). The literature reports serum-saliva correlations for estradiol (Belkien et al., 1985; Worthman, Stallings, and Hofman, 1990 ) that seem lower than the associations reported for other salivary hormones (Granger, Schwartz, Booth, and Arentz, 1999a; Granger, Schwartz, Booth, Curran, and Zakaria, 1999b; Schwartz, Granger, Susman, Gunnar, and Laird, 1998) . Many studies report assay techniques that involve the use of in-house reagents, or complex or time-consuming extractions and/or separations (e.g., Belkien et al., 1985) . In comparison to other commonly assayed salivary markers (i.e., cortisol, sIgA), a rather substantial sample test volume seems required for assay ranging from 0.4 to 5 ml (Belkien et al., 1985; Lu et al., 1999) . There is little literature regarding how to collect saliva to maximize reliability and validity of estradiol results.
When practical aspects of studies preclude salivary measurements, the use of fingerstick blood spots is considered a viable alternative. Blood spot sample collection has received substantial attention because of its routine use during neonatal screenings for metabolic disorders and glucose self-monitoring in diabetics (Knudsen, Slazyk, Richmond, and Hannon, 1993) . Blood spot sample collection and storage appear robust in a wide variety of experimental settings, reliably measuring thyroid hormones (Waite, Maberly, and Eastman, 1987) , prolactin (Bassett, Gross, and Eastman, 1986; Worthman, Stallings, and Gubernick, 1994) , androstenedione (Thomson, Wallace, and Cook, 1989) , cortisol (Kraiem, Kahana, Elias, Ghersin, and Sheinfeld, 1980) , and various gonadotropins (Petsos, Ratcliffe, Heath, and Anderson, 1986; Worthman and Stallings, 1994) including estradiol (Worthman and Stallings, 1997) . Standard procedures for sample collection, handling, and storage are accessible (National Counsel for Clinical Laboratory Standards; NCCLS, 1992) . Although more training is required for blood spots than for saliva collection, blood spots can be easily collected by research assistants and adult subjects' themselves.
The disadvantages of blood spot assays also are noteworthy. Little research is available on the application of blood spot immunoassay protocols outside the markers used in routine neonatal screenings. The fingerstick procedure is less traumatic than venipuncture, but perhaps a larger number of subjects would prefer saliva sampling. This might be especially true when children or adolescents are involved. However Petsos et al. (1986) found that adult female subjects considered repeated blood spot sampling to be the least inconvenient compared to both serum and saliva sampling. Only a handful of studies report that blood spot estradiol assays can be designed to produce valid and reliable results. In one of the more comprehensive papers, Worthman and Stallings (1997) report a protocol with an impressive serum-blood spot correlation for estradiol (r ϭ 0.98), but the literature to date falls short of describing protocols in enough detail to enable method reproduction by other laboratories. There are also questions regarding whether analytical sensitivity of these assays is sufficient to capture the full range of individual differences, especially in prepubertal children or men.
For the reasons outlined above, immunoassays for estradiol in both saliva and blood spots are needed to complete the next generation of studies. The assays need the following features: (1) a low sample test volume (for salivary assay in particular), (2) sufficient sensitivity range to capture the full range of individual differences, (3) an efficient protocol (i.e., no extraction or separation), (4) high correlations with serum, and (5) recommendations for sample collection. We developed protocols that fill these gaps and present them in sufficient detail to permit their direct replication. Assay performance is characterized in terms of specificity, sensitivity, reliability of the standard curve, precision, accuracy, and linearity of dilution. We also compared the external validity of these measures in relation to predicting serum levels and "behavioral" variables.
METHODS

Assay Development
The saliva and blood spot protocols are modifications of the Diagnostic Systems Laboratories (Webster, TX) [ 125 I] double antibody test kit for the quantification of estradiol (third generation) in serum. The estradiol antiserum is rabbit antiestradiol in a protein-based buffer with sodium azide. The antibody cross-reacts 6.90% with estrone and less than 1.00% with equilin, equilenin, and 17␤-estradiol-3-glucuronide. Internal controls contain estradiol in a human serum matrix with sodium azide. External controls are purchased from Bio-Rad (Anaheim, CA; Lyphochek immunoassay control serum); they contain multiple steroids in a human serum matrix. Human specimens in all proceeding experiments were obtained under IRB-approved protocols, and informed consent was obtained.
Salivary Estradiol Assay
Reagent preparation. All calibrators, controls, antibody, and tracers are from DSL-39100 estradiol (third generation) except for the external control (Bio-Rad Lyphochek level I). Zero and nonspecific binding (NSB) calibrators use 100 l of zero standards and 1900 l phosphate-buffered saline (PBS). The 15, 50, and 150 pg/ml serum calibrators are diluted with 1900 l PBS, for the 0.75, 2.50, and 7.50 pg/ml saliva standards. Five hundred microliters of these calibrators are then diluted with 500 l of the diluted zero or NSB for the 0.375, 1.25, and 3.75 pg/ml standards. Internal controls are constructed by diluting 50 l of level I and II controls with 950 l PBS. A third control dilutes Bio-Rad Lyphochek level I ϫ64 with PBS. Antiserum is diluted ϫ4 with PBS. Estradiol tracer [ 125 I ] is diluted ϫ3 with PBS.
Protocol. Saliva samples are thawed, vortexed, and centrifuged at 1500g for 20 min. Polypropylene tubes are labeled in triplicate for total count (TC), NSB, and calibrators. Polypropylene tubes are labeled in duplicate for controls and samples. Three hundred microliters of calibrators, controls, and samples is pipetted into the appropriate tubes. One hundred microliters of antiserum dilution is added to all tubes except TC and NSB. One hundred microliters of PBS is added to NSB tubes. All tubes are vortexed and incubated for 4 h at room temperature (RT). One hundred microliters of the ϫ3 estradiol [
125 I] tracer dilution is added to all tubes. Tubes are vortexed and incubated overnight at 4°C. Afterward, 500 l of precipitating reagent is added to all tubes except TC. All tubes are vortexed and incubated for 20 min at RT. Finally, the tubes are centrifuged at 1500g for 20 min at RT, aspirated or decanted, and counted for 2 min on a ␥-counter (LKB Clinigamma). Results are calculated in pg/ml using either log-linear or logit-log regression.
Blood Spot Estradiol Assay
Reagent preparation. Blood spot calibrators and controls are from DSL-4800 estradiol (ultrasensitive). Antibody and tracer are from DSL-39100 estradiol (third generation). Bio-Rad Lyphochek levels I, II, and III are used for external controls. Calibrators and controls are prepared by mixing equal volumes of washed red blood cells with saline three times (see Worthman and Stallings, 1994) . Fifty microliters is then spotted onto the blood spot collection papers. After drying overnight at RT, the spots are frozen at Ϫ80°C. Antiserum is diluted ϫ4 with PBS containing 0.1% gel. Estradiol tracer [ 125 I ] is diluted ϫ4 with PBS with gel. Protocol. At the time of the assay, calibrators and controls are punched and eluted from the filter paper (No. 903, Schleicher, Schuell, & Keene, NH) by punching eight 1 ⁄8-in. circles from one or more blood spots. Four punched spots are added to each glass tube duplicate. After adding 350 l of PBS with gel to each tube, the tubes are vortexed, covered, and rotated at 300 rpm for 1 h at RT. The tubes are then incubated overnight at 4°C for 18 to 22 h. The next day, the tubes are vortexed and rotated for 1 h at RT, and then the eluate from duplicate tubes is combined into one tube.
Polypropylene tubes are labeled and arranged in duplicate for TC, NSB, calibrators, controls, and samples. Two hundred and fifty microliters of the eluate is pipetted into each tube. One hundred microliters of ϫ4 estradiol antiserum dilution is added to all tubes except TC and NSB. One hundred microliters of PBS with gel is added to the NSB tubes. Tubes are then vortexed, covered, and incubated at RT for 4 h. One hundred microliters of ϫ4 [
125 I] tracer dilution is added to each tube. All tubes are vortexed, covered, and incubated at 4°C for 18 to 22 h. The following day, 500 l of precipitating reagent is added. The tubes are vortexed and incubated at RT for 20 min. The tubes are centrifuged at 1500g for 30 min at RT, aspirated or decanted, and counted for 2 min on a ␥-counter (LKB Clinigamma). Results are calculated in pg/ml using either log-linear or logit-log regression.
RESULTS
Performance Characteristics
Salivary estradiol assay. Analytical sensitivity, 0.25 pg/ml, was determined by interpolating the mean minus two standard deviations for 10 sets of duplicates at the 0 pg/ml standard. The standard curve was highly reproducible with an average correlation coefficient of r ϭ 0.997 (SD ϭ 0.001) across 9 runs. Intraassay variations (CV), determined from the means of 14 replicates each at lower (0.22 pg/ml), midrange (0.67 pg/ml), and higher (4.91 pg/ml) values, were 10.61, 5.91, and 2.83%, respectively. Interassay variations for samples with lower (0.50 pg/ml) and higher (5.06 pg/ml) values were 13.62 and 4.39%. Functional sensitivity, the minimum concentration of estradiol that is measured with an interassay CV% of less than 20.00, was conservatively estimated at 0.50 pg/ml with an interassay CV% of 13.62 (see Table 1 ). Analytical recovery was on average 100.65% (see Table 3 ). Linearity was assessed (1:2 to 1:12 dilutions) across the range of measurements, with an average recovery of 89.25% (range 77.56 to 102.30%; see Table  2 ).
Blood spot estradiol assay. Analytical sensitivity for the blood spot assay was 2.00 pg/ml. Across 22 assays the correlation coefficient averaged r ϭ 0.994 (SD ϭ 0.005). Intraassay CVs were 16.00% for low (42.70 pg/ml), 1.51% for mid (91.50 pg/ml), and 5.21% for high (226.60 pg/ml) values. Interassay variations were 8.93 and 7.51% for low (41.60 pg/ml) and high (235.50 pg/ml) values, respectively. Recoveries for low (34.70 pg/ml expected, 24.50 pg/ml recovered) and high (84.70 pg/ml expected, 75.20 pg/ml recovered) values showed 70.61 and 88.78%, respectively (see Table 3 ). Linearity was evaluated by measuring estradiol in samples diluted 1:2 to 1:8; percentage recovery averaged 108.50% (range 102.25 to 121.90%; see Table 2 ).
Sample Collection
Salivary estradiol assay. Following Granger et al. (1999a,b) , two common techniques used to collect saliva samples (i.e., cotton swabs to absorb sample and chewing gum used to stimulate saliva flow) were evaluated for potential interference with the assay. First, saliva from five individuals was collected by passive drool. Subjects rinsed their mouths with water, waited 5 min, and then expectorated approximately 6 ml of saliva through a short plastic straw into a plastic vial. Next, samples were left untreated (clear), filtered through a cotton dental roll (Richmond, Charlotte, NC) by expressing saliva from the roll using a 10-cc syringe, or filtered through the cotton swab used in the untreated or plain cotton version of the Salivette device (Sarstedt, Newton, NC) by centrifugation. All samples were then stored at Ϫ80°C until assay. Compared to the clear samples, samples collected using cotton dental rolls, t (4) ϭ 9.74, P Ͻ 0.001, and Salivettes, t (4) ϭ 10.74, P Ͻ 0.001, had elevated estradiol results. Means were 0.74 pg/ml (SD ϭ 0.45), 3.30 pg/ml (SD ϭ 0.30), and 3.13 pg/ml (SD ϭ 0.36) for the clear, cotton, and Salivette conditions. Subjects next chewed sugar-free original flavor Trident gum, with samples collected consecutively for 5 min. Compared to the clear samples, gum significantly elevated estradiol results at all five time points, F(5, 25) ϭ 9.342, P Յ 0.001. Simple contrasts revealed that all samples collected using gum had significantly higher estradiol levels at every time point than clear samples (P Ͻ 0.05).
Blood spot estradiol assay. Sample collection and storage methods have been thoroughly standardized for blood spots (NCCLS, 1992; Worthman and Stallings, 1997) . The NCCLS procedures indicate that fingerstick blood spots can be collected by medical technologists, trained researchers, and subjects. One index finger should be warmed to increase the blood flow. The skin should then be wiped clean with an alcohol swab, leaving as little alcohol residue as possible. After the skin is pricked with a lancet (Becton-Dickinson, Franklin Lakes, NJ), the first exudate from the puncture should be wiped from the finger with sterile cotton. Drops of blood should be collected on the filter paper (No. 903, Schleicher, Schuell, & Keene) until the collection circles are completely saturated with blood. Samples should be allowed to air dry at RT. Though samples are relatively robust against temperature and humidity conditions, samples frozen at temperatures of at least Ϫ20°C appear the most stable (Waite et al., 1987) , and humidity at 30% or less is advisable.
Relation to Serum Concentrations
To validate indices of salivary and blood spot biomarkers, we compared their linear relationships to levels in serum and then to each other. Simultaneous serum and saliva were collected from 40 undergraduate students (20 males and 20 females) between the ages of 18 and 27 (M ϭ 20.90 years). Matched blood spots were obtained for all but one male participant. Collection took place between 0800 and 1500 h and followed the NCCLS-recommended protocol described above. Saliva was collected at the same time after subjects rinsed their mouths with water, waited 5 min, and then expectorated 6 -10 ml of saliva into a collection vial. Serum samples were assayed for estradiol using the DSL (Webster, TX) double antibody radioimmunoassay (kit No. 39100), following the recommended protocol for in vitro diagnostic use. The range of analytical sensitivity of the serum assay is from 0.60 to 150 pg/ml, with average inter-and intraassay CV% of 6.80 and 3.60, as reported by the manufacturer (see Table 1 ).
Four females and five males were excluded from the serum-saliva comparison because their salivary estra- diol levels fell below analytical sensitivity. For all males and females, blood spot and serum estradiol levels were above the respective assay analytical sensitivity. The mean serum, saliva, and blood spot levels for males were 32.37 pg/ml (SD ϭ 7.53), 0.53 pg/ml (SD ϭ 0.19), and 26.00 pg/ml (SD ϭ 5.56). The mean serum, saliva, and blood spot levels for females were 70.39 pg/ml (SD ϭ 45.42), 0.98 pg/ml (SD ϭ 0.56), and 46.85 pg/ml (SD ϭ 28.00). On average for males, levels in saliva represented 1.65%, and levels in blood spots reflect 80.29% of the estradiol concentration in serum. On average for females, levels in saliva reflect 3.33%, and levels in blood spots reflect 66.56% of estradiol in serum.
In the combined sample, values obtained for saliva and serum estradiol levels showed a strong linear relationship, r (29) ϭ 0.68, P Ͻ 0.001. This association was stronger for females, r (14) ϭ 0.60, P Ͻ 0.013, than for males, r (13) ϭ Ϫ0.07, ns. The parallel associations obtained for blood spot and serum estradiol levels revealed strong relationships for the overall sample, r (37) ϭ 0.96, P Ͻ 0.001, for males, r (17) ϭ 0.73, P Ͻ 0.001, and for females, r(18) ϭ 0.96, P Ͻ 0.001. The associations between blood spot and saliva estradiol levels were r(28) ϭ 0.74, P Ͻ 0.001 for the combined sample, r(12) ϭ Ϫ0.18, ns for males, and r(14) ϭ 0.72, P Ͻ 0.002 for females. Scatterplots of the serum-saliva and serum-blood spot relationships are presented in Fig. 1 separately for males and females.
Estradiol Levels in Prepubertal and Adult Males and Females
Salivary estradiol assay. Developmental researchers conducting prospective studies need to know whether salivary or blood spot assays for estradiol are sufficiently sensitive to capture the range of individual differences in prepubertal boys and girls and in adult males and changes across the menstrual cycle in adult females. As part of a large ongoing study on hormones and behavior in the family context, saliva samples were collected from the members of 200 families with school-aged children. Following Dabbs (1991) , saliva was collected after subjects chewed original flavor sugar-free Trident gum. After at least 3 min, they deposited 3-6 ml of saliva into a plastic vial. Samples were collected by parents at home immediately after waking and were delivered by mail to the Pennsylvania State University Behavioral Endocrinology Laboratory. A subset of saliva samples from 17 boys (M ϭ 8.56 years, range 8 -9), 18 nonmenstruating girls (M ϭ 11.66 years, range 10.78 -12.27), 19 adult males (M ϭ 40.47 years, range 32-49), and 54 cycling adult females (M ϭ 42.31 years, range 36.20 -51.74) were assayed for estradiol. The majority of boys' (77.78%) and girls' (94.44%) saliva samples returned values above analytical sensitivity. As expected, prepubertal boys had estradiol levels below analytical sensitivity more often than girls, 2 (1, N ϭ 72) ϭ 4.181, P Ͻ 0.05. Mean salivary estradiol levels were 0.83 pg/ml (range Ͻ0.25 to 2.46 pg/ml) for boys and 0.82 pg/ml (range Ͻ0.25 to 2.45 pg/ml) for girls. A total of 97.40% of adult males and 97.89% of adult females returned values above analytical sensitivity. Mean salivary estradiol levels were 1.02 pg/ml (range Ͻ0.25 to 3.93 pg/ml) for adult males and 2.01 pg/ml (range Ͻ0.25 to 6.13 pg/ml) for adult females averaged across the menstrual cycle.
Based on their self-reported menstrual cycle daycount, the females were grouped: days 0 -5 (menstruating, N ϭ 13), days 5-8 (early follicular, N ϭ 8), days 8 -11 (midfollicular, N ϭ 7), days 11-14 (late follicular, N ϭ 8), days 14 -19 (early luteal, N ϭ 3), and day 19ϩ (mid to late luteal, N ϭ 12). Three subjects with estradiol levels below analytical sensitivity were excluded. As expected, salivary estradiol levels varied substantially across the menstrual cycle. Day-count explained 22.80% of the variance in salivary estradiol levels when a cubic estimation was utilized, F(1, 47) ϭ 4.62, P Ͻ 0.007. Estradiol levels were lowest for the menstruation group, M ϭ 1.33 pg/ml (0.60), and higher for the early and midfollicular groups, M ϭ 2.24 pg/ml (1.38) and M ϭ 2.65 pg/ml (1.25), respectively. Estradiol levels were highest for the late follicular group, M ϭ 2.84 pg/ml (1.32). Levels were 2.14 pg/ml (1.10) and 1.44 pg/ml (0.68) for the early luteal group and the mid to late luteal group, respectively. Blood spot estradiol assay. Blood spot data were obtained from a larger project of hormonal correlates of cognitive sex differences (Reavis and Overman, 2000) . Blood spots from 13 boys (M ϭ 12.38 years, range 11 to 13), 10 nonmenstruating girls (M ϭ 12.10, range 11 to 13), 19 older adult males (M ϭ 59.42, SD ϭ 6.01), and 37 adult females (M ϭ 20.04 years, SD ϭ 1.81) were assayed for estradiol. 89.47% of boys' and 100% of girls' blood spots samples returned val-
FIG. 1.
Serum-saliva and serum-blood spot associations for estradiol (pg/ml) by gender. Note: LLAS ϭ Lower limit of analytical sensitivity.
ues above analytical sensitivity. Mean blood spot estradiol levels were 6.95 pg/ml (range Ͻ2.00 to 33.57 pg/ml) for boys and 17.28 pg/ml (range 6.10 to 73.20 pg/ml) for girls. One hundred percent of the adult males and 94.59% of the adult females were within the range of the assay's analytical sensitivity. Mean blood spot estradiol levels were 20.13 pg/ml (range 8.20 to 29.50 pg/ml) for adult males and 50.12 pg/ml (range Ͻ2.00 to 206.20 pg/ml) for adult females. We were unable to perform an analysis on menstrual cycle daycount in adult females in blood spots.
Associative Relationships between Estradiol and Behavior
The purpose of this analysis is to compare the measurement validity of blood spot versus saliva estradiol levels as predictors of expected serum estradiol-behavior correlations. We created a series of computergenerated variables using the equation BV n ϭ (measured SE 2 * b 1 ) ϩ (RND * b 2 ), where BV n indicates a set of simulated behavior variables, and SE 2 represents the level of estradiol in serum measured in samples from the 40 participants in Study 2. RND is a normally distributed random variable with a mean of 5 and a standard deviation of 1. We systematically varied the values of b 1 and b 2 , with the constraint that their sum equaled 1. In this way, we created 10 hypothetical behavior variables (M skewness ϭ 0.24, range 0.003 to 1.22) that are correlated to varying degrees (M correlation ϭ 0.52, range 0.11 to 0.85) with the serum estradiol values obtained in Study 2. Correlations were then computed separately between each behavior variable and the corresponding salivary and blood spot estradiol levels.
The size of the estradiol-behavior correlation was significantly lower when blood spot measurements were substituted for serum estradiol values, t (9) ϭ 2.68, P Ͻ 0.025. When saliva estradiol levels were used, the size of the estradiol-behavior correlation also was significantly underestimated, t (9) ϭ 5.45, P Ͻ 0.001. The average correlations with these behavioral variables were 0.52 (0.27), 0.50 (0.25), and 0.32 (0.22) for serum, blood spots, and saliva, respectively. In other words, salivary estradiol measurements underestimate the size of the expected serum-behavior correlation by 37.55%, whereas blood spot measurements underestimate the size of the expected serumbehavior correlation by only 3.45%.
DISCUSSION
We developed simple, reliable, and highly sensitive assay modifications of commercially available radioimmunoassay kits to measure estradiol in saliva and blood spot specimens. Our analyses reveal that both assays meet rigorous internal validity criteria (Chard, 1990) . Each assay represents an advance over previously published protocols with respect to at least one of the following features: ease-of-use, sample test volume, reproducibility, intra-and interassay CVs, spike recovery, linearity, and range of sensitivity. Analytical sensitivity for blood spot estradiol is sufficient to determine the range of individual differences expected in prepubertal boys and girls, adult males, and adult females across the menstrual cycle. Blood spot assay results are highly correlated with serum estradiol levels for both males and females, and substitution of blood spot assay results for serum results accurately estimates known serum estradiol-behavior correlations.
For salivary estradiol, 22.22% of adolescent boys, 5.56% of adolescent girls, 2.11% of adult females, and 2.63% of adult males were excluded because the levels measured were below analytical sensitivity. Despite substantial improvements in internal validity obtained by the salivary assay developed here, the serum-saliva correlation for estradiol is only modest for females and is not significant for males. Our analyses also reveal that when saliva assay results are substituted for serum, known estradiol-behavior associations are underestimated by an average of 37.55%. The serum-blood spot correlation for estradiol is substantial in both males and females, and blood spots underestimate known estradiol-behavior associations by only 3.45%. The findings have important implications for the use and potential misuse of noninvasive measures of estradiol. Blood spot and salivary sampling may be preferable for research scientists when venipuncture is not possible. However, both measurement techniques have advantages and disadvantages that must be balanced with careful consideration on a project-by-project basis.
To date, we suspect that decisions to use blood spots versus saliva have focused mainly on logistical issues and practical constraints. For instance, saliva's main advantage over blood spots involves possibilities for repeated sampling with minimal trauma. Likewise, practical advantages of blood spots over saliva include standardized collection protocols (NCCLS, 1992) and a large range of biomarkers that can be assayed from these specimens. Our findings suggest that blood spots provide additional advantages over saliva in terms of correlation with serum, possibilities for including adult and prepubertal male subjects, and decreased attenuation of correlations with behavior.
These results highlight a new practical constraint for consideration when collecting saliva samples to be assayed for estradiol. Two of the most commonly used methods are inappropriate for use when investigators intend to conduct assays for estradiol. As with immunoassays for several other salivary biomarkers such as testosterone, DHEA, sIgA, and progesterone (Shirtcliff, Granger, Schwartz, and Curran, 2000) , the use of cotton-based absorbent materials artificially elevates assay results. Consistent with similar reports of gum interference for testosterone (Granger et al., 1999b) and DHEA (Granger et al., 1999a) , our findings suggest that the use of gum to stimulate saliva flow may also interfere with salivary estradiol values. We strongly caution against the use of both cotton-based absorbent materials and gum to obtain samples to be assayed for estradiol. Sample collection techniques need to be extensively pilot tested prior to the initiation of data collection to be certain that procedures do not interfere with the assays to be used.
Previous research has been confirmed which suggests that saliva is a viable alternative to serum when studies must noninvasively measure estradiol levels in females (Lu et al., 1999; Lipson and Ellison, 1996; O'Rourke and Ellison, 1993; Worthman et al., 1990; Belkien et al., 1985; Choe et al., 1982) . The present assay protocol represents an advance because its analytical sensitivity is adequate to assess estradiol in the majority of prepubertal girls. Beyond these confirmatory findings, the analyses reveal that salivary estradiol levels in males may not necessarily reflect levels in the general circulation. A large percentage of estradiol levels may fall below analytical sensitivity in adolescent males. Thus, we question the veridicality of use of salivary measures of estradiol in biobehavioral studies that include males. Research is needed to identify the source of this gender-related measurement discrepancy.
Investigators interested in predicting estradiol-behavior relationships should take note. Estradiol-behavior correlations determined using saliva as a surrogate for serum are likely to substantially underestimate the true relationship. With respect to previously reported studies, it is possible that some studies have been conducted with sample sizes too small to provide adequate statistical power to detect the relations of interest. For future studies, this issue may be resolved by adjusting expected effect sizes in power analyses. For example, following Cohen (1977) , with a sample size of 100 participants and with an expected estradiol-behavior correlation of r ϭ 0.30, the investigators would have adequate statistical power-an 86% chance of obtaining a P value less than 0.05. However, if salivary estradiol was used rather than serum values, we expect to underestimate the strength of the correlation by 37.55%. Thus, the expected estradiol-behavior association would be approximately r ϭ 0.19. With a sample size of 100 participants and with salivary estradiol measures, the investigator would have only a 52% chance of obtaining P Ͻ 0.05. Again following Cohen (1977) , to correct for this reduction in statistical power, an increase in sample size to 200 -250 subjects would be needed to regain an 86% chance of finding significant results at P Ͻ 0.05. By contrast, blood spots would attenuate the expected correlation by only 3%, yielding a correlation of approximately r ϭ 0.29. With a sample of 100, blood spot measures would have an 83.9% chance of obtaining a P Ͻ 0.05. Thus, only a few additional subjects would be needed, if any, to adjust for the expected 3% attenuation of the true estradiol-behavior relationship.
While the results presented are encouraging to researchers interested in salivary and blood spot estradiol measurement, several limitations to the studies should be taken into consideration. The protocol for both salivary and blood spot estradiol does not employ either separation or extraction; therefore, our findings are limited to protocols that employ similar methods. Sample collection methods for salivary estradiol in Study 2 utilized Trident gum, which appears to introduce unsystematic error into sample collection. The fact that salivary estradiol still exhibited expected associations with gender and menstrual cycle variation speaks to the robust nature of these effects, despite the decrease in statistical power. While we were able to see if salivary estradiol could be measured throughout the menstrual cycle, we were unable to conduct this comparison in blood spots. The size of the serum-blood spot correlation in adult females would suggest that blood spots are sensitive to menstrual cycle variation, but this direct comparison remains to be conducted. It is important to consider the levels and percentage detectability reported here as representative of values obtained in the morning when estradiol levels are at their theoretical peak due to the circadian rhythm. Estradiol levels would presumably be substantially lower if samples were collected in the afternoon and evening. Finally, estradiol in serum and blood spots represents both the free and bound hor-mone, whereas saliva measures only the biologically active fraction in the general circulation (Riad-Fahmy et al., 1987; Vining et al., 1983) . Therefore, it is possible that for salivary measures, the attenuation of the serum-behavior correlation (derived from an equation based on serum estradiol) is partially due to this difference. On the other hand, it also is plausible that because salivary levels represent the biologically active fraction of estradiol, results may more accurately reflect the actual estradiol-behavior correlation. Given appropriate collection conditions, sample sizes, and assay procedures, salivary measurement may be more meaningful in some circumstances than blood spot measurement.
In conclusion, contemporary theorists consider hormone-behavior relationships to be dynamic, having reciprocal and potentially nonlinear effects. To extend our understanding of these effects to new limits, appropriate sample types, collection methods, and measurement and statistical techniques must be carefully considered. We recommend that investigators in the early stages of planning studies that involve the use of salivary measures should (a) estimate expected estradiol-behavior effect sizes and, via power analyses, adjust sample sizes appropriately and (b) carefully pilot test sample collection procedures to minimize potential assay interference.
